Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase II trial assessing the safety and efficacy of RSS0309 Ointment in adults with atopic dermatitis; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSS0309 Ointment

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Atopic Dermatitis of Adults | Phase 2 | Status: ACTIVE_NOT_RECRUITING